Neuberger Berman Group’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Buy |
|
|||||
|
2025
Q1 | $926K | Buy |
|
|||||
|
2024
Q4 | $421K | Buy |
|
|||||
|
2024
Q3 | $413K | Buy |
|
|||||
|
2024
Q2 | $205K | Sell |
|
|||||
|
2024
Q1 | $648K | Buy |
|
|||||
|
2023
Q4 | $538K | Sell |
|
|||||
|
2023
Q3 | $14.4M | Buy |
|
|||||
|
2023
Q2 | $16.3M | Sell |
|
|||||
|
2023
Q1 | $19.3M | Sell |
|
|||||
|
2022
Q4 | $21.5M | Buy |
|
|||||
|
2022
Q3 | $21.7M | Buy |
|
|||||
|
2022
Q2 | $22.7M | Buy |
|
|||||
|
2022
Q1 | $15M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $486K | Buy |
|